Researchers believe that combining navitoclax with ruxolitinib might help individuals with myelofibrosis. In this particular trial fifty percent the folks have navitoclax and ruxolitinib. Another 50 percent have ruxolitinib and also a dummy drug (placebo ). In animal research, navitoclax was uncovered to get a senolytic agent, inducing apoptosis in https://mr-l299765.blogdiloz.com/25840124/the-lp-935509-diaries